Upexi, Inc. (NASDAQ:UPXI) Director Buys $30,000.00 in Stock

Upexi, Inc. (NASDAQ:UPXI - Get Free Report) Director Lawrence Dugan purchased 4,000 shares of the business's stock in a transaction dated Tuesday, July 22nd. The shares were purchased at an average price of $7.50 per share, for a total transaction of $30,000.00. Following the purchase, the director owned 116,389 shares of the company's stock, valued at approximately $872,917.50. This trade represents a 3.56% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Lawrence Dugan also recently made the following trade(s):

• On Wednesday, July 16th, Lawrence Dugan purchased 11,000 shares of Upexi stock. The stock was bought at an average cost of $5.69 per share, with a total value of $62,590.00.
• On Tuesday, July 15th, Lawrence Dugan purchased 1,000 shares of Upexi stock. The shares were purchased at an average cost of $5.17 per share, with a total value of $5,170.00.

Upexi Trading Down 3.8%

Shares of NASDAQ:UPXI traded down $0.23 during trading on Monday, hitting $5.88. The stock had a trading volume of 8,314,196 shares, compared to its average volume of 12,209,046. The company has a current ratio of 0.37, a quick ratio of 0.24 and a debt-to-equity ratio of 0.31. Upexi, Inc. has a 12-month low of $1.90 and a 12-month high of $22.57. The stock has a 50-day simple moving average of $7.96 and a two-hundred day simple moving average of $5.96.

Upexi (NASDAQ:UPXI - Get Free Report) last posted its quarterly earnings results on Friday, May 16th. The company reported ($2.87) earnings per share (EPS) for the quarter. Upexi had a negative return on equity of 535.19% and a negative net margin of 135.86%. The business had revenue of $3.16 million for the quarter.

Analyst Upgrades and Downgrades

UPXI has been the topic of several research analyst reports. Cantor Fitzgerald raised shares of Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 target price on the stock in a research report on Monday, June 16th. Wall Street Zen raised shares of Upexi to a "hold" rating in a report on Friday, May 30th.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Kathmere Capital Management LLC purchased a new stake in Upexi in the second quarter valued at $6,535,000. North Star Investment Management Corp. acquired a new position in shares of Upexi in the 2nd quarter valued at about $45,000. Finally, Bank of Montreal Can purchased a new stake in shares of Upexi in the fourth quarter worth about $36,000. Hedge funds and other institutional investors own 5.68% of the company's stock.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.